New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...

Quote Panel

Shape
Updated June 30, 2025
1W 2.94 % 1M 5.53 % 3M 25.75 % 1Y -13.58 %

Key Metrics

Shape
  • Market Cap

    1.49B


  • Shares Outstanding

    355.11M


  • Share in Float

    336.74M


  • Dividende

    0


  • Earning Date

    13 Aug 2025


  • Price Target

    4.2


  • Average Volume

    132432


  • Beta

    1.086


  • Range

    2.84-5.64


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.evotec.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

EVO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape437%

2026-Revenue

$0.08

Shape17%

2026-EPS

$96M

Shape451%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Jefferies

downgrade

Previous: Not converted

2024-10-07

Now: Hold

Deutsche Bank

downgrade

Previous: Hold

2024-08-08

Now: Sell

Oddo BHF

downgrade

Previous: Not converted

2024-08-07

Now: Neutral

Morgan Stanley

downgrade

Previous: Overweight

2024-07-29

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-0.04
vs -0.08

Q3.23

arrow
arrow

N/A

-0.12
vs -0.26

Q4.23

arrow
arrow

N/A

-0.05
vs -0.13

Q1.24

arrow
arrow

N/A

-0.05
vs -0.08

Q2.24

arrow
arrow

N/A

-0.29
vs -0.04

Q3.24

arrow
arrow

N/A

-0.12
vs -0.12

Q4.24

arrow
arrow

N/A

-0.12
vs -0.05

Q1.25

arrow
arrow

N/A

-0.19
vs -0.05

Q2.25

arrow
arrow

N/A

-0.04
vs -0.29

Q3.25

arrow
arrow

N/A

-0.04
vs -0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-1%

170.3M  vs 172.2M

Q3.23

arrow
arrow

+13%

196.3M  vs 173.9M

Q4.23

arrow
arrow

-16%

201.3M  vs 240.7M

Q1.24

arrow
arrow

-2%

208.7M  vs 213.6M

Q2.24

arrow
arrow

+7%

182.1M  vs 170.3M

Q3.24

arrow
arrow

-6%

184.9M  vs 196.3M

Q4.24

arrow
arrow

+10%

221.2M  vs 201.3M

Q1.25

arrow
arrow

-4%

200M  vs 208.7M

Q2.25

arrow
arrow

+25%

228.2M  vs 182.1M

Q3.25

arrow
arrow

+28%

237.2M  vs 184.9M

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

-1%

-0.01
vs -0.01

Q3.23

arrow
arrow

-3%

-0.03
vs -0.01

Q4.23

arrow
arrow

-1%

-0.01
vs -0.03

Q1.24

arrow
arrow

-2%

-0.02
vs -0.01

Q2.24

arrow
arrow

-9%

-0.09
vs -0.02

Q3.24

arrow
arrow

-4%

-0.04
vs -0.09

Q4.24

arrow
arrow

-4%

-0.04
vs -0.04

Q1.25

arrow
arrow

-3%

-0.03
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q2.23

arrow
arrow

20

20
vs 18

11%

Q3.23

arrow
arrow

24

24
vs 20

20%

Q4.23

arrow
arrow

28

28
vs 24

17%

Q1.24

arrow
arrow

21

21
vs 28

-25%

Q2.24

arrow
arrow

28

28
vs 21

33%

Q3.24

arrow
arrow

24

24
vs 28

-14%

Q4.24

arrow
arrow

26

26
vs 24

8%

Q1.25

arrow
arrow

25

25
vs 26

-4%

Earnings Growth

Latest News